Stratec SE
SBS
Rank in Stocks
#14221
Established in 1979 and headquartered in Birkenfeld, Germany, Stratec SE... Established in 1979 and headquartered in Birkenfeld, Germany, Stratec SE (previously known as STRATEC Biomedical AG until its name change in December 2018) specializes in the development and manufacturing of cutting-edge automation and instrumentation systems. The company caters to the in-vitro diagnostics and life sciences sectors, operating across Germany, the European Union, and globally. Its business is divided into three primary segments: Instrumentation, Diatron, and Smart Consumables. The Instrumentation segment focuses on designing and fabricating automated analytical systems, along with necessary spare parts and supplies, for customers in clinical diagnostics and biotechnology. The Diatron segment provides a suite of systems, components, disposables, and assays for lower-volume hematology and clinical chemistry applications. Finally, the Smart Consumables segment is dedicated to engineering and producing intelligent consumables for the diagnostics, life sciences, and medical technology industries.
Share Price
$27.72
Last synced: 2026-11-09
Market Cap
$336.96M
Change (1 day)
-0.54%
Change (1 year)
11.29%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Stratec SE (SBS)
Category
Healthcare
EPS for Stratec SE (SBS)
EPS as of June 2026 TTM: $-0.04
According to Stratec SE's latest financial reports, its current EPS (TTM) is $-0.04. At the end of 2025 the company had an EPS of $-0.02, a decrease compared to its 2024 EPS of $1.37.
EPS history for Stratec SE from 2002 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.04 | 123.00% |
| 2025 | $-0.02 | -101.70% |
| 2024 | $1.37 | -1.39% |
| 2023 | $1.39 | -46.12% |
| 2022 | $2.59 | -31.11% |
| 2021 | $3.75 | 27.32% |
| 2020 | $2.95 | 118.90% |
| 2019 | $1.35 | 56.21% |
| 2018 | $0.86 | -66.75% |
| 2017 | $2.59 | 49.29% |
| 2016 | $1.74 | -14.50% |
| 2015 | $2.03 | -0.11% |
| 2014 | $2.03 | 11.98% |
| 2013 | $1.82 | 29.82% |
| 2012 | $1.40 | -18.18% |
| 2011 | $1.71 | 12.11% |
| 2010 | $1.52 | 3.20% |
| 2009 | $1.48 | 96.24% |
| 2008 | $0.75 | 0.00% |
| 2007 | 0.00 | 0.00% |
| 2006 | 0.00 | -100.00% |
| 2005 | $0.51 | 33.82% |
| 2004 | $0.38 | 77.35% |
| 2003 | $0.21 | 85.53% |
| 2002 | $0.12 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $2.70 | -6,153.81% |
US
|
|
| $4.09 | -9,270.40% |
IE
|
|
| $9.45 | -21,288.34% |
US
|
|
| $2.37 | -5,413.90% |
US
|
|
| $1.77 | -4,068.61% |
US
|
Questions about Stratec SE's earnings per share (EPS)
What is Stratec SE's earnings per share (EPS)?
Stratec SE's earnings per share (EPS) over the last twelve months is $-0.04, as of Jun 2026.
What was Stratec SE's earnings per share (EPS) in 2025?
In 2025, Stratec SE's earnings per share (EPS) was $-0.02, compared with $1.37 in 2024.
How has Stratec SE's earnings per share (EPS) changed since 2020?
From 2020 to 2025, Stratec SE's earnings per share (EPS) was highest in 2021 ($3.75) and lowest in 2025 ($-0.02).
How does Stratec SE's earnings per share (EPS) compare with similar companies?
Stratec SE's earnings per share (EPS) ($-0.04) is lower than that of all 5 similar companies listed above. The highest among them is Stryker Corporation, with $9.45.